Neal Shah, MD, PhD

I am a native of Long Island and am thrilled to be back and serving its communities. I have spent 17 years in doctoral-level academics, choosing Dermatology for its unique blend of seeing patients in clinic, performing same-day outpatient surgeries, helping patients achieve the looks they want with cosmetics, and exploring exciting new therapeutic options that have revolutionized the way chronic medical conditions are treated. I am well-versed in all fields of Dermatology, particularly sclerotherapy (leg vein therapy) and all types of nail conditions. I am passionate about academics and medical education, continuing to stay informed of emerging therapy and treatment guidelines to deliver the best of care. With all my patients, I strive to be compassionate and comprehensive as we have a conversation about options and create an individualized treatment plan.

Shah N, Liu Z, Tallman RM, Mohammad A, Sprowls SA, Saralkar PA, Vickers SD, Pinti MV, Gao W, Lockman PR. Drug resistance occurred in a newly characterized preclinical model of lung cancer brain metastasis. BMC Cancer. 2020 Apr 7;20(1):292. doi: 10.1186/s12885-020-06808-2.

Liu Z, Shah N, Marshall KL, Sprowls SA, Saralkar P, Mohammad A, Blethen KE, Arsiwala TA, Fladeland R, Lockman PR, Gao W. Overcoming the acquired resistance to gefitinib in lung cancer brain metastasis in vitro and in vivo. Arch Toxicol. 2021 Nov;95(11):3575-3587. doi: 10.1007/s00204-021-03147-4.

Sprowls SA, Saralkar P, Arsiwala T, Adkins CE, Blethen KE, Pizzuti VJ, Shah N, Fladeland R, Lockman PR. A Review of Mathematics Determining Solute Uptake at the Blood-Brain Barrier in Normal and Pathological Conditions. Pharmaceutics. 2021 May 19;13(5):756. doi: 10.3390/pharmaceutics13050756.

Sprowls SA, Arsiwala TA, Bumgarner JR, Shah N, Lateef SS, Kielkowski BN, Lockman PR. Improving CNS Delivery to Brain Metastases by Blood-Tumor Barrier Disruption. Trends Cancer. 2019 Aug;5(8):495-505. doi: 10.1016/j.trecan.2019.06.003.

Zhao H, Martin E, Matalkah F, Shah N, Ivanov A, Ruppert JM, Lockman PR, Agazie YM.
Conditional knockout of SHP2 in ErbB2 transgenic mice or inhibition in HER2-amplified breast cancer cell lines blocks oncogene expression and tumorigenesis. Oncogene. 2019 Mar;38(13):2275-2290. doi: 10.1038/s41388-018-0574-8.

Shah N, Mohammad AS, Saralkar P, Sprowls SA, Vickers SD, John D, Tallman RM, Lucke-Wold BP, Jarrell KE, Pinti M, Nolan RL, Lockman PR. Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases. Pharmacol Res. 2018 Jun;132:47-68. doi: 10.1016/j.phrs.2018.03.021.

Mohammad AS, Griffith JI, Adkins CE, Shah N, Sechrest E, Dolan EL, Terrell-Hall TB, Hendriks BS, Lee H, Lockman PR. Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer. Pharm Res
. 2018 Jan 9;35(2):31. doi: 10.1007/s11095-017-2278-0.

Mohammad AS, Adkins CE, Shah N, Aljammal R, Griffith JIG, Tallman RM, Jarrell KL, Lockman PR. Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer. BMC Cancer. 2018 Dec 7;18(1):1225.
Zhao H, Martin E, Matalkah F, Shah N, Ivanov A, Ruppert JM, Lockman PR, Agazie YM. Conditional knockout of SHP2 in ErbB2 transgenic mice or inhibition in HER2-amplified breast cancer cell lines blocks oncogene expression and tumorigenesis. Oncogene. 2018 Nov 22
Iqbal S, Rattu MA, Shah N. Role of PARP Inhibitors in BRCA-Related Malignancies. US Pharm. 2018;9(43):HS-10-HS16.

Shah N, Mohammad AS, Saralkar P, Sprowls SA, Vickers SD, John D, Tallman RM, Lucke-Wold BP, Jarrell KE, Pinti M, Nolan RL, and Lockman PR. Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases. Pharmacol Res. 2018 Mar 28.

Shah N, Jalali O, Glover B, Zinn Z. A 5-year retrospective review of contact dermatitis patch testing in West Virginia. W V Med J. July-Aug 2018. Mohammad AS, Griffith JI, Adkins CE, Shah N, Sechrest E, Dolan EL, Terrell-Hall TB, Hendriks BS, Lee H, Lockman PR. Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer. Pharm Res. 2018 Jan 9;35(2):31. doi: 10.1007/s11095-017-2278-0.

Lucke-Wold B, Avula R, Shah N, Borah G, Shrader C. IV Infiltration and Latex Allergy in an Infant: Early Recognition is Key to Prevent Lasting Disability. Clin Pediatr Dermatol. 2017, 3:1.
Bohn KA, Adkins CE, Mittapalli RK, Terrell-Hall TB, Mohammad AS, Shah N, Dolan EL, Nounou MI, and Lockman PR. Semi-automated Rapid Quantification of Brain Vessel Density Utilizing Fluorescent Microscopy. J Neurosci Methods. 2016 Jun 16

Kozyreva VK, Kiseleva A, Ice RJ, Jones BC, Loskutov YV, Matalkah F, Smolkin MB, Marinak K, Livengood RH, Salkeni MA, Wen S, Hazard HW, Layne GP, Walsh CM, Cantrell P, KilbyGW, Mahavadi S, Shah N, and Pugacheva EN. Combination of Eribulin and Aurora A inhibitor MLN8237 prevents metastatic colonization and induces cytotoxic autophagy in breast cancer. Mol Cancer Ther. 2016 May 27.

Adkins CE, Mohammad AS, Terrell-Hall TB, Dolan EL, Shah N, Sechrest E, Griffith J, and Lockman PR. Characterization of passive permeability at the blood-tumor barrier in five preclinical models of brain metastases of breast cancer. Clin Exp Metastasis. 2016 Apr;33(4):373-83.
Wang S, Saha R, Shah N, Hanna A, DeMuro J, Calixte R, Brathwaite C. Effect of Intravenous Acetaminophen on Postoperative Opioid Use in Bariatric Surgery Patients. P.T. 2015 Dec;40(12):847-50.

Rattu MA, Shah N, Iskhakova I, Popovitz B. The Utility of FLT3 Inhibitors in Acute Myeloid Leukemia. US Pharm. 2014;39(11)(Specialty&Oncology suppl):8-11.
Shah N, Rattu MA. Reversal Agents for Anticoagulants: Focus on Andexanet Alfa. AMSRJ. 2014 Spring;1(1):16-28.

Rattu MA, Shah N, Lee JM, Pham AQ, Marzella N. Glucarpidase (Voraxaze®), a Carboxypeptidase Enzyme for Methotrexate Toxicity. P T. 2013:38(12):732-744.

Rattu MA, Shah N, Singhal S, Marzella N. The Role of Pharmacists in the Management of Acute Kidney Stones. US Pharm. 2013;38(8).

Rattu MA, Shah N, Marzella N. The Role of Pharmacists in Tetanus Management and Prevention. US Pharm. 2013;38(5):39-52.

Wang S, Shah N, Philip J, Caraccio T, Feuerman M, and Malone B. Role of Alvimopan (Entereg) in Gastrointestinal Recovery and Hospital Length of Stay After Bowel Resection. P T. 2012 Sep;37(9):518-25.